![Keith R. Frank](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Keith R. Frank
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IGL Pharma, Inc.
![]() IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Presidente | 01/01/2016 | - |
Fundador | 01/01/2016 | - | |
IsoTherapeutics Group LLC
![]() IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Director Ejecutivo | 01/01/2005 | - |
Fundador | 01/01/2005 | - | |
Presidente | 01/01/2005 | - |
Historial de carrera de Keith R. Frank
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Founder | 2 |
Chairman | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
IGL Pharma, Inc.
![]() IGL Pharma, Inc. Medical/Nursing ServicesHealth Services IGL Pharma, Inc. provides health care services. The company was founded in 2016 by Keith R. Frank and Jamie Simon and is headquartered in Angleton, TX. | Health Services |
IsoTherapeutics Group LLC
![]() IsoTherapeutics Group LLC BiotechnologyHealth Technology Part of Telix Pharmaceuticals Ltd., IsoTherapeutics Group LLC is a radiopharmaceutical company that offers technologies for developing novel therapeutic and diagnostic agents. The company is based in Angleton, TX. The company was founded in 2005 by Jaime Simon, Keith R. Frank. Keith R. Frank has been the CEO of the company since 2005. IsoTherapeutics Group was acquired by Telix Pharmaceuticals Ltd. on April 09, 2024 for $13.63 million. | Health Technology |
- Bolsa de valores
- Insiders
- Keith R. Frank
- Experiencia